Beclomethasone dipropionate: II: Allergic rhinitis and other conditions.
At doses similar to those used in the treatment of chronic bronchial asthma, intranasal beclomethasone dipropionate is effective in alleviating nasal symptoms of seasonal allergic and perennial rhinitis in about three-quarters of patients. Eye symptoms are not relieved. The carry-over effect of the evening dose is useful in preventing early morning attacks of sneezing. Intranasal beclomethasone dipropionate is useful in controlling symptoms persisting after polypectomy and may possibly delay or eliminate the need for the surgical removal of nasal polyps, which may shrink after several weeks or months of treatment.
D000281:Administration, Intranasal; D000311:Adrenal Glands / Q000187:drug effects; D000328:Adult; D001507:Beclomethasone / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004205:Cromolyn Sodium / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008775:Methylprednisolone / Q000031:analogs & derivatives*; D009298:Nasal Polyps / Q000188:drug therapy; D010919:Placebos; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*; D012621:Seasons
D010919:Placebos; D001507:Beclomethasone; D004205:Cromolyn Sodium; D006854:Hydrocortisone; D008775:Methylprednisolone